Page last updated: 2024-08-23

pimonidazole and contrast agent p792

pimonidazole has been researched along with contrast agent p792 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Backes, W; Boterberg, T; Bouckenooghe, I; Ceelen, W; De Visschere, M; Demetter, P; Pattyn, P; Peeters, M; Smeets, P; Van Damme, N	1

Other Studies

1 other study(ies) available for pimonidazole and contrast agent p792

Article	Year
Noninvasive monitoring of radiotherapy-induced microvascular changes using dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) in a colorectal tumor model. International journal of radiation oncology, biology, physics, 2006, Mar-15, Volume: 64, Issue:4 Topics: Animals; Capillary Permeability; Cell Hypoxia; Cell Line, Tumor; Colorectal Neoplasms; Contrast Media; Heterocyclic Compounds; Magnetic Resonance Imaging; Male; Microcirculation; Models, Animal; Nitroimidazoles; Organometallic Compounds; Oxygen; Partial Pressure; Radiation-Sensitizing Agents; Rats; Vascular Endothelial Growth Factor A	2006

Article

Year

Noninvasive monitoring of radiotherapy-induced microvascular changes using dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) in a colorectal tumor model.

International journal of radiation oncology, biology, physics, 2006, Mar-15, Volume: 64, Issue:4

Topics: Animals; Capillary Permeability; Cell Hypoxia; Cell Line, Tumor; Colorectal Neoplasms; Contrast Media; Heterocyclic Compounds; Magnetic Resonance Imaging; Male; Microcirculation; Models, Animal; Nitroimidazoles; Organometallic Compounds; Oxygen; Partial Pressure; Radiation-Sensitizing Agents; Rats; Vascular Endothelial Growth Factor A

2006